Improving mental health and quality of life for young cancer survivors and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on pediatric and adolescent patients diagnosed with solid tumors and their primary caregivers, assessing their cognitive and psycho-social functions. Following the assessment, participants will receive personalized counseling and educational sessions aimed at enhancing their mental health and overall quality of life. The interventions are delivered on a one-on-one basis to ensure tailored support. The study targets individuals in the acute-transitional survival period, which spans from active treatment to two years post-treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Those between the ages of 10 and 24, and diagnosed with pediatric solid tumor, who are undergoing treatment or survivors who have completed the treatment and the treatment end date is within 2 years.
* Parent or legal guardian who is a primary caregiver to children and adolescent patient of acute-transitional phase.
* Those whose cognitive ability is capable of verbal counseling and who agrees to the evaluation assessment.

Exclusion Criteria:

* Those who disagree to participate as a research subject.
* Those whose psycho-emotional state requires professional treatment or medical conditions precludes intervention.
* Those undergoing treatment and children and adolescent survivors of acute-transitional phase, whose prior intelligence assessment FSIQ score is less than 70. However, if the GAI score is 70 or higher, participation is possible after the principal investigator's interview, with linguistic competence taken into consideration.

Elimination Criteria:

* Those who withdraw consent of this research.
* Those who have difficulty participating due to worsening of disease or decease of patient.

Where it's running

• National Cancer Center
  Goyang-si, Gyonggi-do, South Korea Recruiting
• Seoul National University Children's Hospital
  Seoul, Seoul, South Korea Recruiting
• Tree and Forest Psychological Counseling Center
  Seoul, Seoul, South Korea Active not recruiting

Study contacts

• Principal investigator: Principal Investigator — National Cancer Center
• Study coordinator: Principal Investigator
• Email: jooyoungcasa@ncc.re.kr
• Phone: +82) 031-902-1724

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adaptive Proton Therapy for Pediatric Solid Tumors and Hodgkin Lymphoma

  This study tests a regular imaging approach to see if proton therapy plans for children with solid tumors or Hodgkin lymphoma should be updated during treatment.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07514819

• Understanding the tumor microenvironment in children's solid tumors to improve adoptive cell therapy

  We will analyze tumor samples from children with solid tumors to see if features of the tumor environment can help guide better adoptive T cell therapy.

  Recruiting Fondazione IRCCS Policlinico San Matteo di Pavia · Pavia, Pavia · NCT07240207

• Testing GAIA-102 for difficult-to-treat pediatric cancers

  This study is testing a new treatment called GAIA-102 for children with tough-to-treat cancers to see if it’s safe and how much of it they should get.

  Recruiting Phase 1 Kyushu University · Fukuoka, Fukuoka · NCT05608148

• Molecular analysis of pediatric solid tumors

  This study is trying to understand the genetic and molecular features of different childhood solid tumors to find better ways to treat these tough cancers.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT01050296

• Becotatug Vedotin for EGFR-positive relapsed, refractory, or metastatic pediatric solid tumors

  This trial will test Becotatug Vedotin, an EGFR-targeted antibody-drug conjugate, to see if it is safe and helps children aged 2–18 with EGFR-positive relapsed, refractory, or metastatic solid tumors.

  Recruiting Phase 1 Sun Yat-sen University · Guangzhou, Guangdong · NCT07584499

• B7-H3 CAR T cells for relapsed or refractory solid tumors in children and young adults

  This study tests a new B7-H3 CAR T cell therapy to see if it is safe and can help kids and young adults whose solid tumors have come back or stopped responding to standard treatments.

  Recruiting Phase 1 Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07358260

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.